Elevated circulating interleukin-27 in patients with coronary artery disease is associated with dendritic cells, oxidized low-density lipoprotein, and severity of coronary artery stenosis

Mediators of Inflammation

Volumn 2012, Issue , 2012, Pages

  Jin, Wen ^a   Zhao, Yiqiao ^a   Yan, Wen ^a   Cao, Longxing ^b   Zhang, Weiwei ^b   Wang, Ming ^c   Zhang, Ting ^a   Fu, Qiang ^b   Li, Zhiliang ^b  

^a GUANGDONG SECOND PROVINCIAL GENERAL HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 27; INTERLEUKIN 27 EBI3; INTERLEUKIN 27 P28; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG; INTERLEUKIN 17; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CELL MATURATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENSINI SCORE; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SUBUNIT; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; UPREGULATION; BLOOD; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; CORONARY STENOSIS; DENDRITIC CELLS; FEMALE; HUMANS; INTERLEUKIN-17; LIPOPROTEINS, LDL; MALE; MIDDLE AGED;

EID: 84864946567     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2012/506283     Document Type: Article

References (64)

1. Anderson G. F., Chu E., Expanding priorities-Confronting chronic disease in countries with low income The New England Journal of Medicine 2007 356 3 209 211 (Pubitemid 46143222)
2. Hansson G. K., Hermansson A., The immune system in atherosclerosis Nature Immunology 2011 12 3 204 212
3. Joffre O., Nolte M. A., Sprri R., Sousa C. R. E., Inflammatory signals in dendritic cell activation and the induction of adaptive immunity Immunological Reviews 2009 227 1 234 247
4. Kushwah R., Hu J., Complexity of dendritic cell subsets and their function in the host immune system Immunology 2011 133 4 409 419
5. Adema G. J., Dendritic cells from bench to bedside and back Immunology Letters 2009 122 2 128 130
6. Cybulsky M. I., Jongstra-Bilen J., Resident intimal dendritic cells and the initiation of atherosclerosis Current Opinion in Lipidology 2010 21 5 397 403
7. Niessner A., Weyand C. M., Dendritic cells in atherosclerotic disease Clinical Immunology 2010 134 1 25 32
8. Koltsova E. K., Ley K., How dendritic cells shape atherosclerosis Trends in Immunology 2011 32 11 540 547
9. Andersson J., Libby P., Hansson G. K., Adaptive immunity and atherosclerosis Clinical Immunology 2010 134 1 33 46
10. Taleb S., Tedgui A., Mallat Z., Adaptive T cell immune responses and atherogenesis Current Opinion in Pharmacology 2010 10 2 197 202
11. Lu X., Lu D., Narayan U., Kakkar V. V., The role of T-helper cells in atherosclerosis Cardiovascular and Hematological Agents in Medicinal Chemistry 2011 9 1 25 41
12. Hunter C. A., New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions Nature Reviews Immunology 2005 5 7 521 531 (Pubitemid 40961330)
13. Devergne O., Hummel M., Koeppen H., Le Beau M. M., Nathanson E. C., Kieff E., Birkenbach M., A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes Journal of Virology 1996 70 2 1143 1153 (Pubitemid 26029036)
14. Pflanz S., Timans J. C., Cheung J., Rosales R., Kanzler H., Gilbert J., Hibbert L., Churakova T., Travis M., Vaisberg E., Blumenschein W. M., Mattson J. D., Wagner J. L., To W., Zurawski S., McClanahan T. K., Gorman D. M., Bazan J. F., De Waal Malefyt R., Rennick D., Kastelein R. A., IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4 + T cells Immunity 2002 16 6 779 790 (Pubitemid 34786477)
15. Pflanz S., Hibbert L., Mattson J., Rosales R., Vaisberg E., Fernando Bazan J., Phillips J. H., McClanahan T. K., De Waal Malefyt R., Kastelein R. A., WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27 Journal of Immunology 2004 172 4 2225 2231 (Pubitemid 38182370)
16. Chen Q., Ghilardi N., Wang H., Baker T., Xie M. H., Gurney A., Grewal I. S., De Sauvage F. J., Development of Th1-type immune responses requires the type I cytokine receptor TCCR Nature 2000 407 6806 916 920
17. Sprecher C. A., Grant F. J., Baumgartner J. W., Presnell S. R., Schrader S. K., Yamagiwa T., Whitmore T. E., O'Hara P. J., Foster D. F., Cloning and characterization of a novel class I cytokine receptor Biochemical and Biophysical Research Communications 1998 246 1 82 90 (Pubitemid 28413931)
18. Yoshida H., Hamano S., Senaldi G., Covey T., Faggioni R., Mu S., Xia M., Wakeham A. C., Nishina H., Potter J., Saris C. J. M., Mak T. W., WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection Immunity 2001 15 4 569 578 (Pubitemid 33016442)
19. Yoshida H., Nakaya M., Miyazaki Y., Interleukin 27: a double-edged sword for offense and defense Journal of Leukocyte Biology 2009 86 6 1295 1303
20. Stamatelopoulos K. S., Lekakis J. P., Tseke P., Ikonomidis I., Kollias G. E., Alevizaki M., Kanakakis I., Voidonikola P., Zakopoulos N., Papamichael C. M., Differential associations of renal function with coronary and peripheral atherosclerosis International Journal of Cardiology 2009 135 2 162 164
21. Alber H. F., Duftner C., Wanitschek M., Drler J., Schirmer M., Suessenbacher A., Frick M., Dichtl W., Pachinger O., Weidinger F., Neopterin, CD4 + CD28 - lymphocytes and the extent and severity of coronary artery disease International Journal of Cardiology 2009 135 1 27 35
22. Zaguri R., Verbovetski I., Atallah M., Trahtemberg U., Krispin A., Nahari E., Leitersdorf E., Mevorach D., 'Danger' effect of low-density lipoprotein (LDL) and oxidized LDL on human immature dendritic cells Clinical and Experimental Immunology 2007 149 3 543 552 (Pubitemid 47256159)
23. Johnston N., Jernberg T., Lagerqvist B., Siegbahn A., Wallentin L., Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease International Journal of Cardiology 2006 113 2 167 173 (Pubitemid 44648400)
24. Hansson G. K., Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease The New England Journal of Medicine 2005 352 16 1685 1626
25. Takeda A., Hamano S., Yamanaka A., Hanada T., Ishibashi T., Mak T. W., Yoshimura A., Yoshida H., Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment Journal of Immunology 2003 170 10 4886 4890 (Pubitemid 36554716)
26. Artis D., Villarino A., Silverman M., He W., Thornton E. M., Mu S., Summer S., Covey T. M., Huang E., Yoshida H., Koretzky G., Goldschmidt M., Wu G. D., De Sauvage F., Miller H. R. P., Saris C. J. M., Scott P., Hunter C. A., The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity Journal of Immunology 2004 173 9 5626 5634 (Pubitemid 39392150)
27. Yoshimoto T., Yoshimoto T., Yasuda K., Mizuguchi J., Nakanishi K., IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation Journal of Immunology 2007 179 7 4415 4423
28. Batten M., Li J., Yi S., Kljavin N. M., Danilenko D. M., Lucas S., Lee J., de Sauvage F. J., Ghilardi N., Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells Nature Immunology 2006 7 9 929 936 (Pubitemid 44263906)
29. Stumhofer J. S., Laurence A., Wilson E. H., Huang E., Tato C. M., Johnson L. M., Villarino A. V., Huang Q., Yoshimura A., Sehy D., Saris C. J. M., O'Shea J. J., Hennighausen L., Ernst M., Hunter C. A., Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system Nature Immunology 2006 7 9 937 945 (Pubitemid 44263907)
30. Hamano S., Himeno K., Miyazaki Y., Ishii K., Yamanaka A., Takeda A., Zhang M., Hisaeda H., Mak T. W., Yoshimura A., Yoshida H., WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production Immunity 2003 19 5 657 667 (Pubitemid 37490791)
31. Villarino A., Hibbert L., Lieberman L., Wilson E., Mak T., Yoshida H., Kastelein R. A., Saris C., Hunter C. A., The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection Immunity 2003 19 5 645 655 (Pubitemid 37490790)
32. Awasthi A., Carrier Y., Peron J. P. S., Bettelli E., Kamanaka M., Flavell R. A., Kuchroo V. K., Oukka M., Weiner H. L., A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells Nature Immunology 2007 8 12 1380 1389 (Pubitemid 350131175)
33. Summers S. A., Phoon R. K. S., Ooi J. D., Holdsworth S. R., Kitching A. R., The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responses American Journal of Pathology 2011 178 2 580 590
34. Siebler J., Wirtz S., Frenzel C., Schuchmann M., Lohse A. W., Galle P. R., Neurath M. F., Cutting edge: a key pathogenic role of IL-27 in T cell-mediated hepatitis Journal of Immunology 2008 180 1 30 33
35. Nieuwenhuis E. E. S., Neurath M. F., Corazza N., Iijima H., Trgovcich J., Wirtz S., Glickman J., Bailey D., Yoshida M., Galle P. R., Kronenberg M., Birkenbach M., Blumberg R. S., Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice Proceedings of the National Academy of Sciences of the United States of America 2002 99 26 16951 16956 (Pubitemid 36034079)
36. Yoshizaki A., Yanaba K., Iwata Y., Komura K., Ogawa A., Muroi E., Ogawa F., Takenaka M., Shimizu K., Hasegawa M., Fujimoto M., Sato S., Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation Annals of the Rheumatic Diseases 2011 70 1 194 200
37. Rajaiah R., Puttabyatappa M., Polumuri S. K., Moudgil K. D., Interleukin-27 and interferon- are involved in regulation of autoimmune arthritis Journal of Biological Chemistry 2011 286 4 2817 2825
38. Miyazaki Y., Inoue H., Matsumura M., Matsumoto K., Nakano T., Tsuda M., Hamano S., Yoshimura A., Yoshida H., Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-deficient mice Journal of Immunology 2005 175 4 2401 2407 (Pubitemid 41113850)
39. Fujita H., Teng A., Nozawa R., Takamoto-Matsui Y., Katagiri-Matsumura H., Ikezawa Z., Ishii Y., Production of both IL-27 and IFN- after the treatment with a ligand for invariant NK T cells is responsible for the suppression of TH2 response and allergic inflammation in a mouse experimental asthma model Journal of Immunology 2009 183 1 254 260
40. Batten M., Li J., Yi S., Kljavin N. M., Danilenko D. M., Lucas S., Lee J., de Sauvage F. J., Ghilardi N., Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells Nature Immunology 2006 7 9 929 936 (Pubitemid 44263906)
41. Fitzgerald D. C., Ciric B., Touil T., Harle H., Grammatikopolou J., Das Sarma J., Gran B., Zhang G. X., Rostami A., Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis Journal of Immunology 2007 179 5 3268 3275
42. Fitzgerald D. C., Zhang G. X., El-Behi M., Fonseca-Kelly Z., Li H., Yu S., Saris C. J., Gran B., Ciric B., Rostami A., Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells Nature Immunology 2007 8 12 1372 1379 (Pubitemid 350131174)
43. Lee Y. S., Amadi-Obi A., Yu C. R., Egwuagu C. E., Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10 Immunology 2011 132 4 492 502
44. Rosas L. E., Satoskar A. A., Roth K. M., Keiser T. L., Barbi J., Hunter C., De Sauvage F. J., Satoskar A. R., Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to Leishmania donovani infection but develop severe liver immunopathology American Journal of Pathology 2006 168 1 158 169 (Pubitemid 43062569)
45. Steinman R. M., Cohn Z. A., Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution Journal of Experimental Medicine 1973 137 5 1142 1162
46. Rossi M., Young J. W., Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity Journal of Immunology 2005 175 3 1373 1381 (Pubitemid 41023036)
47. Bobryshev Y. V., Dendritic cells and their role in atherogenesis Laboratory Investigation 2010 90 7 970 984
48. Van Vré E. A., Hoymans V. Y., Bult H., Lenjou M., Van Bockstaele D. R., Vrints C. J., Bosmans J. M., Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease Coronary Artery Disease 2006 17 3 243 248 (Pubitemid 44324834)
49. Yilmaz A., Weber J., Cicha I., Stumpf C., Klein M., Raithel D., Daniel W. G., Garlichs C. D., Decrease in circulating myeloid dendritic cell precursors in coronary artery disease Journal of the American College of Cardiology 2006 48 1 70 80 (Pubitemid 43929209)
50. Van Brussel I., Van Vré E. A., De Meyer G. R. Y., Vrints C. J., Bosmans J. M., Bult H., Decreased numbers of peripheral blood dendritic cells in patients with coronary artery disease are associated with diminished plasma Flt3 ligand levels and impaired plasmacytoid dendritic cell function Clinical Science 2011 120 9 415 426
51. Su W., Sun A., Xu D., Zhang H., Yang L., Yuan L., Jia J., Zou Y., Wu Y., Wang K., Ge J., Tongxinluo inhibits oxidized low-density lipoprotein-induced maturation of human dendritic cells via activating peroxisome proliferator-activated receptor gamma pathway Journal of Cardiovascular Pharmacology 2010 56 2 177 183
52. Ramadan M. M., Kodama M., Hirono S., Okura Y., Mitsuma W., Ito M., Aizawa Y., Evaluation of oxidized low-density lipoprotein in the coronary circulation of patients with coronary artery disease, and its association with percutaneous coronary intervention International Journal of Cardiology 2009 134 3 e117 e119
53. Ishigaki Y., Oka Y., Katagiri H., Circulating oxidized LDL: a biomarker and a pathogenic factor Current Opinion in Lipidology 2009 20 5 363 369
54. Itabe H., Obama T., Kato R., The dynamics of oxidized LDL during atherogenesis Journal of Lipid 2011 2011 9
55. Ait-Oufella H., Taleb S., Mallat Z., Tedgui A., Recent advances on the role of cytokines in atherosclerosis Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 5 969 979
56. Bobryshev Y. V., Lord R. S. A., Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of vascular dendritic cells in athero-resistant and athero-prone areas of the normal aorta Archives of Histology and Cytology 1995 58 3 307 322
57. Paulson K. E., Zhu S. N., Chen M., Nurmohamed S., Jongstra-Bilen J., Cybulsky M. I., Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis Circulation Research 2010 106 2 383 390
58. Jongstra-Bilen J., Haidari M., Zhu S. N., Chen M., Guha D., Cybulsky M. I., Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis Journal of Experimental Medicine 2006 203 9 2073 2083 (Pubitemid 44352229)
59. Liu P., Yu Y. R. A., Spencer J. A., Johnson A. E., Vallanat C. T., Fong A. M., Patterson C., Patel D. D., CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 2 243 250 (Pubitemid 351161195)
60. Yilmaz A., Lochno M., Traeg F., Cicha I., Reiss C., Stumpf C., Raaz D., Anger T., Amann K., Probst T., Ludwig J., Daniel W. G., Garlichs C. D., Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques Atherosclerosis 2004 176 1 101 110 (Pubitemid 39078651)
61. Bobryshev Y. V., Lord R. S. A., Co-accumulation of dendritic cells and natural killer T cells within rupture-prone regions in human atherosclerotic plaques Journal of Histochemistry and Cytochemistry 2005 53 6 781 785 (Pubitemid 40726958)
62. Kawahara I., Kitagawa N., Tsutsumi K., Nagata I., Hayashi T., Koji T., The expression of vascular dendritic cells in human atherosclerotic carotid plaques Human Pathology 2007 38 9 1378 1385 (Pubitemid 47247481)
63. Erbel C., Sato K., Meyer F. B., Kopecky S. L., Frye R. L., Goronzy J. J., Weyand C. M., Functional profile of activated dendritic cells in unstable atherosclerotic plaque Basic Research in Cardiology 2007 102 2 123 132 (Pubitemid 46189953)
64. Van Vré E. A., Bosmans J. M., Van Brussel I., Maris M., De Meyer G. R., Van Schil P. E., Vrints C. J., Bult H., Immunohistochemical characterisation of dendritic cells in human atherosclerotic lesions: possible pitfalls Pathology 2011 43 3 239 247